Skip to main content

In Vitro Fertilization

1
Pipeline Programs
4
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Innovation Pharmaceuticals
1 program
1
Medium with no human serum albumine addedPhase 21 trial
Active Trials
NCT00541892Withdrawn0Est. Jan 2014
IBSA Institut Biochimique
IBSA Institut BiochimiqueSwitzerland - Lugano-Pazzallo
2 programs
ProgesteronePHASE_31 trial
ProgesteronePHASE_31 trial
Active Trials
NCT00827983Completed683Est. May 2011
NCT00828191Completed800Est. Feb 2012
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Estrogen Levels and Postoperative Recovery in IVF PatientsN/A1 trial
Active Trials
NCT06925633CompletedEst. Dec 2025
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
Gonal -f® [r-hFSH]PHASE_41 trial
Active Trials
NCT01210144Terminated27Est. Aug 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.Gonal -f® [r-hFSH]
IBSA Institut BiochimiqueProgesterone
IBSA Institut BiochimiqueProgesterone
Innovation PharmaceuticalsMedium with no human serum albumine added
City TherapeuticsEstrogen Levels and Postoperative Recovery in IVF Patients

Clinical Trials (5)

Total enrollment: 1,510 patients across 5 trials

NCT01210144Merck & Co.Gonal -f® [r-hFSH]

EXpression PRofile Endometrium Samples Study

Start: Aug 2008Est. completion: Aug 201027 patients
Phase 4Terminated
NCT00827983IBSA Institut BiochimiqueProgesterone

Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)

Start: Jan 2009Est. completion: May 2011683 patients
Phase 3Completed
NCT00828191IBSA Institut BiochimiqueProgesterone

Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)

Start: Dec 2008Est. completion: Feb 2012800 patients
Phase 3Completed
NCT00541892Innovation PharmaceuticalsMedium with no human serum albumine added

Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine

Start: Sep 2007Est. completion: Jan 20140
Phase 2Withdrawn
NCT06925633City TherapeuticsEstrogen Levels and Postoperative Recovery in IVF Patients

Estrogen Levels and Postoperative Recovery in IVF Patients

Start: Apr 2025Est. completion: Dec 2025
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.